Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Inflamm Bowel Dis

Search In Journal Title:

Abbravation: Inflammatory Bowel Diseases

Search In Journal Abbravation:

Publisher

Narnia

Search In Publisher:

DOI

10.1016/0921-5093(93)90397-w

Search In DOI:

ISSN

1078-0998

Search In ISSN:
Search In Title Of Papers:

Nitric Oxide and Colitis Rats Humans and Now Mac

Authors: Hawkey C J
Publish Date: 1996/08/01
Volume: 2, Issue: 3, Pages: 225-226
PDF Link

Abstract

Nitric oxide molecule of the year in 1992 is interesting but perplexing for gastroenterologists On the one hand small amounts of nitric oxide synthesized by constitutive forms of nitric oxide in response to stimuli that elevate intracellular calcium are beneficial These beneficial effects include physiological vasodilatation and an antiinflammatory effect mediated by decreased leukocyteendothelial interactions However inflammatory stimuli including particularly lipopolysaccharide interferon interleukin1 and tumor necrosis factor α stimulate expression of a second inducible form of nitric oxide synthase NOS This inducible nitric oxide synthase iNOS is not responsive to environmental stimuli and results in essentially uncontrolled synthesis of amounts of nitric oxide that are two to three orders

Keywords:

References

.
Search In Abstract Of Papers:
Other Papers In This Journal:
  1. Gender and Location of CRC in IBDImplications for Surveillance Protocols
  2. Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent
  3. Targeting TNF in Postoperative Recurrence of Crohn's Disease:Can We Extinguish the Fire Before It Starts?
  4. Gene Expression Profiling Identifies Mechanisms of Protection to Recurrent Trinitrobenzene Sulfonic Acid Colitis Mediated by Probiotics
  5. Adalimumab Therapy in Crohn's Disease of the Ileal Pouch
  6. Observations on Severity and Activity Indices in a Therapeutic Trial of Active Crohn's Disease
  7. Splenic function and IgM-memory B cells in Crohn's disease patients treated with infliximab
  8. One-year Investigator-blind Randomized Multicenter Trial Comparing Asacol 2.4 g Once Daily with 800 mg Three Times Daily for Maintenance of Remission in Ulcerative Colitis
  9. Role of diet in the development of inflammatory bowel disease
  10. Thromboembolism in pediatric inflammatory bowel disease: Systematic review
  11. Potential Oncogenic Properties of Mobilized Stem Cells in a Subpopulation of Inflammatory Bowel Disease Patients Infected with Helicobacter pylori
  12. Potential Oncogenic Properties of Mobilized Stem Cells in a Subpopulation of Inflammatory Bowel Disease Patients Infected with Helicobacter pylori
  13. Twin Studies Reveal Specific Imbalances in the Mucosaassociated Microbiota of Patients with Ileal Crohn's Disease
  14. Microbial Causation of the Chronic Idiopathic Inflammatory Bowel Diseases
  15. Babesiosis in a Patient on Infliximab for Crohn's Disease
  16. Plasma Chromogranin A in Patients With Inflammatory Bowel Disease: A Possible Explanation
  17. Effect of Adalimumab on Clinical Laboratory Parameters in Patients with Crohn's Disease: Results from the CHARM Trial
  18. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease
  19. What is the incidence, prevalence, and natural history of indeterminate colitis?
  20. Anti-tumor Necrosis Factor and Postoperative Complications in Crohn's Disease: Systematic Review and Meta-analysis
  21. Effects of T cell-induced colonic inflammation on epithelial barrier function†
  22. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients
  23. Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine a in patients with steroid resistant ulcerative colitis
  24. Dangers associated with endoscopic management of strictures in IBD
  25. Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's disease†
  26. Role of the interleukin 24 in patients with ulcerative colitis
  27. Antibodies Against Cyclic Citrullinated Peptide (CCP) in Inflammatory Bowel Disease Patients With or Without Arthritic Manifestations
  28. Distinct Microbiome in Pouchitis Compared to Healthy Pouches in Ulcerative Colitis and Familial Adenomatous Polyposis
  29. Is Crohn's creeping fat an adipose tissue?
  30. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease
  31. Cyclosporine in the management of severe ulcerative colitis while breast-feeding
  32. Nailing down the shingles in IBD
  33. Local Injection of Infliximab in Symptomatic Isolated Mucosal LesionsA Novel Scenario for Endoscopic Therapy?
  34. A New Type of Strictureplasty for the Treatment of Multiple Long Stenosis in Crohn's Disease
Search Result: